XRAY - DENTSPLY SIRONA Inc.
| Previous Close | 56.94 |
| Open | 56.86 |
| Bid | 56.34 x 900 |
| Ask | 56.54 x 800 |
| Day's Range | 56.11 - 57.21 |
| 52 Week Range | 34.93 - 60.15 |
| Volume | 854,057 |
| Avg. Volume | 1,539,804 |
| Market Cap | 13B |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | 78.96 |
| EPS (TTM) | 0.71 |
| Earnings Date | Feb 28, 2020 - Mar 3, 2020 |
| Forward Dividend & Yield | 0.40 (0.70%) |
| Ex-Dividend Date | 2019-12-26 |
| 1y Target Est | 62.27 |
- GlobeNewswire
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Dec. 11, 2019 -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a.
- Zacks
XRAY or ALGN: Which Is the Better Value Stock Right Now?
XRAY vs. ALGN: Which Stock Is the Better Value Option?
- Zacks
Why Is Dentsply (XRAY) Up 1.7% Since Last Earnings Report?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Insider Monkey
DENTSPLY SIRONA Inc. (XRAY): Hedge Funds In Wait-and-See Mode
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) based on that […]
- Zacks
3 Orthodontic Stocks to Keep an Eye On
Growth in the orthodontics market has been primarily led by rising focus of vendors on emerging markets, such as Asia-Pacific and LAMEA.
- American City Business Journals
Why this IT recruiting firm sees opportunity in Charlotte
Frank Recruitment Group, an IT recruiting firm headquartered in the United Kingdom, recently opened its ninth stateside office in uptown Charlotte.
- Zacks
Here's Why You Should Add Veeva (VEEV) to Your Portfolio Now
Buoyed by a solid fiscal third quarter, Veeva (VEEV) raises its fiscal 2020 revenue guidance.
- Barrons.com
The 3 Best-Performing Health Care Stocks of 2019 So Far
The S&P 500 Health Care index has underperformed the market in 2019, up 15.2% to the S&P 500’s 25.8%. Shares of Edwards Lifesciences, which sells heart valves and monitoring equipment, are up 60.8% so far this year. In August, the Food and Drug Administration approved two Edwards devices, SAPIEN 3 and SAPIEN 3 Ultra, for a broader set of patients, following the release of positive trial results earlier in the year.
- GuruFocus.com
Top 5 Holdings of Al Gore's Generation Investment Management
Firm of former US vice president keeps adding to Google-parent position Continue reading...
- ACCESSWIRE
Apteryx Imaging Inc. Reports 2019 Third Quarter Results
VANCOUVER, BC / ACCESSWIRE / November 26, 2019 / Apteryx Imaging Inc. ("Apteryx" or the "Company"), a leading dental imaging technology provider focused on delivering state-of-the-art ...
- Zacks
Here's Why You Should Retain McKesson (MCK) Stock for Now
McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market. However, rising pricing pressure remains a concern.
- Zacks
Here's Why You Should Hold on to Surmodics (SRDX) Stock Now
Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.
- Zacks
XRAY vs. ALGN: Which Stock Should Value Investors Buy Now?
XRAY vs. ALGN: Which Stock Is the Better Value Option?
- Zacks
Here's Why You Should Retain PRA Health (PRAH) Stock Now
PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, escalating direct costs remain a woe.
- Zacks
Here's Why You Should Hold on to Becton, Dickinson Stock Now
Becton, Dickinson (BDX) expects tariffs to impact its bottom line in first-quarter fiscal 2020.
- Zacks
Cooper Companies' CVI Unit Gets FDA Nod, To Boost Eye Health
Cooper Companies' (COO) CVI Unit has receives FDA approval for its MiSight 1 day contact lens, which complements its commitment to eye health innovation.
- Simply Wall St.
Should You Think About Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Now?
Let's talk about the popular DENTSPLY SIRONA Inc. (NASDAQ:XRAY). The company's shares saw a decent share price growth...
- Zacks
Here's Why You Should Hold Cooper Companies (COO) Stock Now
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex continues to remain a concern.
- Zacks
NextGen's Medfusion Buyout to Improve Patient Experience
NextGen (NXGN) showcases new capabilities and services for its flagship NextGen Enterprise platform.
- Thomson Reuters StreetEvents
Edited Transcript of XRAY earnings conference call or presentation 7-Nov-19 1:30pm GMT
Q3 2019 Dentsply Sirona Inc Earnings Call
- Zacks
Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?
Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Ups '19 View
DENTSPLY SIRONA (XRAY) gains from solid segmental contributions in Q3.
- Zacks
Dentsply International (XRAY) Beats Q3 Earnings and Revenue Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of 14.00% and 1.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Dentsply Sirona Reports Third Quarter 2019 Financial Performance
Reported Q3 revenues of $962 millionRevenues increased 3.7% on a Reported basis, and increased 7.5% on an Internal sales growth basisGAAP EPS of $0.38 increased 192% YoY..
- Zacks
Medical Products' Nov 7 Earnings Roster: ABC, CAH & More
Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.
